In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Aussie Research Finds Schizophrenia Drugs Prevent Some Cancers

This article was originally published in PharmAsia News

Executive Summary

Australian researchers suggest some drugs for treating schizophrenia also have the ability to treat certain types of cancer. The scientists found that people with schizophrenia had lower rates of cancer. The finding was particularly true relative to lung cancer although schizophrenics are considered more likely to smoke. The research suggests previous assertions that drugs such as pimozide taken to treat schizophrenia also inhibit the growth of cells responsible for lung, breast and brain cancer. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC072064

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel